encainide has been researched along with Disease Models, Animal in 5 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
| De Clerck, F; Lu, HR; Remeysen, P | 1 |
| Gehret, JR; Kothstein, T; Lynch, JJ; Stupienski, RF; Wallace, AA | 1 |
| Antonaccio, MJ; Buchanan, JO; Fleming, JS; Iben, LG; Yocca, FD | 1 |
| Jarenwattananon, M; Nudel, DB; Tribble, J; Weinhouse, E | 1 |
5 other study(ies) available for encainide and Disease Models, Animal
| Article | Year |
|---|---|
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
Antifibrillary action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Chromans; Disease Models, Animal; Electric Stimulation; Electrocardiography; Encainide; Ethanolamines; Guinea Pigs; Heart; Heart Conduction System; Injections, Intravenous; Male; Metoprolol; Nebivolol; Phenethylamines; Piperidines; Sotalol; Sulfonamides; Ventricular Fibrillation; Verapamil | 1995 |
Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disease Models, Animal; Dogs; Electric Stimulation; Electrophysiology; Encainide; Female; Heart Ventricles; Injections, Intravenous; Male; Myocardial Infarction | 1993 |
Effect of encainide, ODE, MODE, and flecainide on ADP/5-HT induced platelet aggregation and in the anesthetized dog coronary artery stenosis-occlusion model of intravascular thrombosis.
Topics: Adenosine Diphosphate; Anilides; Animals; Anti-Arrhythmia Agents; Coronary Circulation; Coronary Thrombosis; Disease Models, Animal; Dogs; Encainide; Flecainide; Heart Rate; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin; Ventricular Function, Left | 1991 |
Reevaluation of digoxin-encainide interactions using an animal model.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Digoxin; Disease Models, Animal; Drug Interactions; Electrocardiography; Encainide; Male; Rats; Rats, Inbred Strains; Tachycardia, Ectopic Atrial; Tachycardia, Supraventricular | 1988 |